Generation Bio Co
NASDAQ:GBIO

Watchlist Manager
Generation Bio Co Logo
Generation Bio Co
NASDAQ:GBIO
Watchlist
Price: 1.83 USD -10.73%
Market Cap: 122.1m USD
Have any thoughts about
Generation Bio Co?
Write Note

Generation Bio Co
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Generation Bio Co
Stock-Based Compensation Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Generation Bio Co
NASDAQ:GBIO
Stock-Based Compensation
$24.3m
CAGR 3-Years
43%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Stock-Based Compensation
$872m
CAGR 3-Years
8%
CAGR 5-Years
16%
CAGR 10-Years
14%
Gilead Sciences Inc
NASDAQ:GILD
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Stock-Based Compensation
$685.6m
CAGR 3-Years
18%
CAGR 5-Years
15%
CAGR 10-Years
16%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Generation Bio Co's Stock-Based Compensation?
Stock-Based Compensation
24.3m USD

Based on the financial report for Dec 31, 2023, Generation Bio Co's Stock-Based Compensation amounts to 24.3m USD.

What is Generation Bio Co's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
47%

Over the last year, the Stock-Based Compensation growth was 0%. The average annual Stock-Based Compensation growth rates for Generation Bio Co have been 43% over the past three years , 47% over the past five years .

Back to Top